Business Context and Reporting Period
Company: Akers Biosciences, Inc. (Ticker: AKER)
Filing Type: Form 8-K (Current Report)
Date of Report: November 17, 2020
Event: Closing of a previously announced private placement of common stock and warrants.
Key Financial Metrics
This filing reports on a specific capital raise event rather than periodic financial performance. Key metrics include:
- Gross Proceeds: Approximately $18.1 million.
- Shares Issued: 9,765,933 shares of common stock.
- Warrants Issued to Investors: Warrants to purchase 9,765,933 shares of common stock.
- Placement Agent Warrant: Warrant to purchase up to 390,368 shares at an exercise price of $1.85 per share.
- Warrant Term: Five and a half years from the date of issuance.
Note: The filing text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity positions.
Material Changes
The primary material change is the increase in the company's capital base following the closing of the private placement. The company issued new equity and warrant instruments, resulting in immediate cash inflow of approximately $18.1 million.
Outlook, Risks, and Management Commentary
Management Commentary: The filing confirms the successful execution of the private placement and the issuance of the placement agent warrant to Katalyst Securities LLC. The placement agent warrant is exercisable at any time following issuance.
Risks and Contingencies: The filing does not explicitly detail new risks or contingencies beyond the standard dilution implications of issuing new shares and warrants. The description of the placement agent warrant is qualified by reference to Exhibit 4.1.
Investor Verification Checklist
- Verify the final closing price per share to calculate the exact dilution impact on existing shareholders.
- Review Exhibit 4.1 for the full terms and conditions of the Placement Agent Warrant.
- Confirm the use of proceeds for the $18.1 million raised, as this filing does not specify the allocation of funds.
- Check subsequent filings for any updates on the company's cash position or burn rate following this capital raise.